Quick Answer
InMed Pharmaceuticals Inc. reported Total Assets of $15.58 million for fiscal year 2025.
InMed Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $15.58M | +31.8% |
| 2024 | $11.82M | -16.2% |
| 2023 | $14.11M | +10.3% |
| 2022 | $12.79M | +30.7% |
| 2021 | $9.78M | +25.4% |
| 2020 | $7.80M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $11.19M | +31.6% | -16.2% |
| September 30, 2025 | $13.36M | +27.7% | -14.2% |
| June 30, 2025 | $15.58M | +31.8% | +67.9% |
| March 31, 2025 | $9.28M | -30.5% | +9.1% |
| December 31, 2024 | $8.50M | -44.3% | -18.8% |
| September 30, 2024 | $10.47M | -4.1% | -11.5% |
| June 30, 2024 | $11.82M | -16.2% | -11.5% |
| March 31, 2024 | $13.36M | -9.3% | -12.4% |
- InMed Pharmaceuticals Inc. showed an increase of +31.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, InMed Pharmaceuticals Inc.’s total assets has grown by 99.7% (from $7.80 million to $15.58 million).
- The most recent figure is from InMed Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: